Outcome of nucleos(t)ide analog intervention in patients with preventive or on‐demand therapy for hepatitis B virus reactivation-Reference-Cited by-同舟云学术

Outcome of nucleos(t)ide analog intervention in patients with preventive or on‐demand therapy for hepatitis B virus reactivation

Published:2020-10-05 Issue:6 Volume:93 Page:3679-3687
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J Med Virol

Author:

Tamori Akihiro¹^ORCID,Kimura Kiminori²^ORCID,Kioka Kiyohide³,Enomoto Hirayuki⁴,Odagiri Naoshi¹,Kozuka Ritsuzo¹,Uchida‐Kobayashi Sawako¹,Enomoto Masaru¹^ORCID,Kawada Norifumi¹,Mizokami Masashi⁵

Affiliation:

1. Department of Hepatology Osaka City University Graduate School of Medicine Osaka Japan

2. Department of Hepatology Tokyo Metropolitan Komagome Hospital Tokyo Japan

3. Department of Hepatology Osaka City General Hospital Osaka Japan

4. Department of Internal Medicine, Division of Gastroenterology and Hepatology Hyogo College of Medicine Nishinomiya Japan

5. Genome Medical Sciences Project, National Center for Global Health and Medicine Tokyo Japan

Funder

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.26526

Reference19 articles.

1. Hepatitis B Virus Reactivation After Cytotoxic Chemotherapy: The Disease and Its Prevention

2. Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions

3. American Gastroenterological Association Institute Technical Review on Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy

4. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

5. WHO

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of Cessation of Nucleos(t)ide Analog Administration on Hepatitis B Virus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Retrospective Study;Transplantation and Cellular Therapy;2024-03

2. Impact of HBcrAg levels on HBsAg seroconversion after HBV rebound: a case report;Journal of Pharmaceutical Health Care and Sciences;2023-12-19

3. Outcome of nucleos(t)ide analog cessation in patients with treatment for prevention of or against hepatitis B virus reactivation;Hepatology Research;2022-12-16

4. Management of hepatitis B virus (HBV) reactivation in patients with resolved HBV infection based on a highly sensitive HB core‐related antigen assay;Hepatology Research;2022-03-09

5. Tenofovir alafenamide for prevention and treatment of hepatitis B virus reactivation and de novo hepatitis;JGH Open;2021-08-19